Cell & Gene
At Eurofins CDMO we deliver end-to-end solutions for Cell and Gene therapy development and manufacturing, supporting the path from preclinical stages up to commercial success. Science and Quality are our foundations and they allow us to deliver sustainable and flexible solutions tailored to the project specific needs, while supporting a timely milestone achievement, every step of the way from R&D to full GMP compliance.
Moreover, thanks to Eurofins network, an unparalleled QC capacity is offered in house leveraging both platform analytical methods and custom product-specific assays.
Molecular Therapies:
- Plasmid DNA (pDNA) manufacturing from R&D to full GMP grade
- Recombinant protein (e.g. nucleases) process development and manufacturing in full GMP compliance
- Development and Manufacturing of Lipid Nano Particles (LNP) formulations for RNA
- Establishment of Master Cell Banks (MCB) and Working Cell Banks (WCB)
Cell&Gene Therapies:
- Process development and optimization of adherent (e.g. MSC) and suspension (e.g. CD34+, T cells and NK) cells
- Gene Editing with Viral and Non-Viral manufacturing platforms
Viral Vectors:
- Packaging plasmids (LVV)
- Lentiviral Vector (LVV) production
